We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
-13.37%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$654M
AUM Growth
-$479M
Cap. Flow
-$300M
Cap. Flow %
-45.83%
Top 10 Hldgs %
100%
Holding
1
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
JUNO
Juno Therapeutics, Inc.
JUNO
+$300M

Sector Composition

Rank Sector Weight
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
$654M 100%
17,348,799
-8,600,000
-33% -$300M

Similar funds

Crestline Management's Q1 2016 Portfolio in Review

As of Q1 2016, Crestline Management held 1 position worth $654M, down 42% from $1.13B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Crestline Management withdrew a net $300M in Q1 2016, reducing 1 holding. Its largest reduction was Juno Therapeutics, Inc., cutting an estimated $300M.

  • Crestline Management's biggest Q1 2016 reduction was Juno Therapeutics, Inc., cutting an estimated $300M.
  • Crestline Management's ten largest holdings make up 100% of its $654M portfolio in Q1 2016.
  • Crestline Management opened 0 new positions and closed 0 in Q1 2016.
  • Crestline Management's portfolio value fell 42% quarter-over-quarter to $654M.

Based on Crestline Management's 13F filing for Q1 2016, filed 13 May 2016.